InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
6
Disclosed sells
0
T+90 hit rate
43%
T+90 mean return
+1.2%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by LIEBERMAN GERALD M, Director. Officer active across 2 companies, notably Teva Pharmaceutical Industries Ltd. Cumulatively, 17 disclosures have been recorded. Breakdown: 6 buys · 0 sell. Total volume traded: €81k. History available since 18 January 2022. The latest transaction was disclosed on 1 April 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations17 total
23,952 shares@ US$1.0021.6% of flowOrdinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-25-001192:0
10,717 shares0Ordinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-25-000156:0
11,269 shares0Ordinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-24-003216:0
27,261 shares0Ordinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-24-002887:0
21,108 sharesOrdinary SharesSEC:0000950170-24-074009:0
23,952 shares@ US$0.7115.0% of flowOrdinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-23-003988:0
Ideal exit: 17 Sept 2024 (T+270)
20,000 shares@ US$0.589210.5% of flowOrdinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-23-002974:0
Ideal exit: 17 May 2024 (T+270)
15,810 sharesOrdinary SharesSEC:0001209191-23-044783:0
34,000 shares@ US$0.5718.3% of flowOrdinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-22-004052:0
Ideal exit: 11 Aug 2023 (T+270)
19,491 shares@ US$1.68331.2% of flowOrdinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-22-002762:0
Ideal exit: 17 Apr 2023 (T+270)
14,479 sharesOrdinary SharesSEC:0001209191-22-037248:0
700 shares@ US$2.80030.0028% mcap50.0% of flowOrdinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-22-000217:0
Ideal exit: 15 Oct 2022 (T+270)
700 shares@ US$2.80031.7% of flowOrdinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-22-000217
Ideal exit: 15 Oct 2022 (T+270)
12,668 sharesOrdinary SharesSEC:0001209191-21-039371:0
12,668 sharesOrdinary SharesSEC:0001209191-21-039371
6,041 sharesOrdinary SharesSEC:0001209191-21-038815:0
6,041 sharesOrdinary SharesSEC:0001209191-21-038815
17 of 17 declarations
About LIEBERMAN GERALD M
LIEBERMAN GERALD M serves as a Board Member at TEVA PHARMACEUTICAL INDUSTRIES LTD and Entera Bio Ltd. He contributes to corporate governance by participating in strategy development and overseeing company performance. His experience in the pharmaceutical sector allows him to provide valuable insights to the board.
